Global IBS-C Drug Market Research Report 2019

1 Study Coverage

• 1.1 IBS-C Drug Product Introduction
• 1.2 Market Segments
• 1.3 Key IBS-C Drug Manufacturers Covered: Ranking by Revenue
• 1.4 Market by Type
  • 1.4.1 Global IBS-C Drug Market Size Growth Rate by Type
  • 1.4.2 Linaclotide
  • 1.4.3 Lubiprostone
  • 1.4.4 Osmotic Laxatives
  • 1.4.5 Stimulant Laxatives
  • 1.4.6 Other
• 1.5 Market by Application
  • 1.5.1 Global IBS-C Drug Market Size Growth Rate by Application
  • 1.5.2 Hospital Pharmacies
  • 1.5.3 Retail Pharmacies
  • 1.5.4 Online Pharmacies
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global IBS-C Drug Market Size, Estimates and Forecasts
  • 2.1.1 Global IBS-C Drug Revenue 2015-2026
  • 2.1.2 Global IBS-C Drug Sales 2015-2026
• 2.2 Global IBS-C Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.2.1 Global IBS-C Drug Retrospective Market Scenario in Sales by Region: 2015-2020
  • 2.2.2 Global IBS-C Drug Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global IBS-C Drug Competitor Landscape by Players

• 3.1 IBS-C Drug Sales by Manufacturers
  • 3.1.1 IBS-C Drug Sales by Manufacturers (2015-2020)
  • 3.1.2 IBS-C Drug Sales Market Share by Manufacturers (2015-2020)
• 3.2 IBS-C Drug Revenue by Manufacturers
  • 3.2.1 IBS-C Drug Revenue by Manufacturers (2015-2020)
  • 3.2.2 IBS-C Drug Revenue Share by Manufacturers (2015-2020)
  • 3.2.3 Global IBS-C Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
  • 3.2.4 Global Top 10 and Top 5 Companies by IBS-C Drug Revenue in 2019
  • 3.2.5 Global IBS-C Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 IBS-C Drug Price by Manufacturers
• 3.4 IBS-C Drug Manufacturing Base Distribution, Product Types
  • 3.4.1 IBS-C Drug Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers IBS-C Drug Product Type
  • 3.4.3 Date of International Manufacturers Enter into IBS-C Drug Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global IBS-C Drug Market Size by Type (2015-2020)
  • 4.1.1 Global IBS-C Drug Sales by Type (2015-2020)
  • 4.1.2 Global IBS-C Drug Revenue by Type (2015-2020)
  • 4.1.3 IBS-C Drug Average Selling Price (ASP) by Type (2015-2026)
• 4.2 Global IBS-C Drug Market Size Forecast by Type (2021-2026)
  • 4.2.1 Global IBS-C Drug Sales Forecast by Type (2021-2026)
  • 4.2.2 Global IBS-C Drug Revenue Forecast by Type (2021-2026)
  • 4.2.3 IBS-C Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
• 4.3 Global IBS-C Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

• 5.1 Global IBS-C Drug Market Size by Application (2015-2020)
  • 5.1.1 Global IBS-C Drug Sales by Application (2015-2020)
  • 5.1.2 Global IBS-C Drug Revenue by Application (2015-2020)
  • 5.1.3 IBS-C Drug Price by Application (2015-2020)
• 5.2 IBS-C Drug Market Size Forecast by Application (2021-2026)
  • 5.2.1 Global IBS-C Drug Sales Forecast by Application (2021-2026)
  • 5.2.2 Global IBS-C Drug Revenue Forecast by Application (2021-2026)
  • 5.2.3 Global IBS-C Drug Price Forecast by Application (2021-2026)

6 North America

• 6.1 North America IBS-C Drug by Country
  • 6.1.1 North America IBS-C Drug Sales by Country
  • 6.1.2 North America IBS-C Drug Revenue by Country
  • 6.1.3 U.S.
  • 6.1.4 Canada
• 6.2 North America IBS-C Drug Market Facts & Figures by Type
• 6.3 North America IBS-C Drug Market Facts & Figures by Application

7 Europe

• 7.1 Europe IBS-C Drug by Country
  • 7.1.1 Europe IBS-C Drug Sales by Country
  • 7.1.2 Europe IBS-C Drug Revenue by Country
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 U.K.
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe IBS-C Drug Market Facts & Figures by Type
• 7.3 Europe IBS-C Drug Market Facts & Figures by Application

8 Asia Pacific

• 8.1 Asia Pacific IBS-C Drug by Region
  • 8.1.1 Asia Pacific IBS-C Drug Sales by Region
  • 8.1.2 Asia Pacific IBS-C Drug Revenue by Region
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 South Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Taiwan
  • 8.1.9 Indonesia
  • 8.1.10 Thailand
  • 8.1.11 Malaysia
  • 8.1.12 Philippines
  • 8.1.13 Vietnam
• 8.2 Asia Pacific IBS-C Drug Market Facts & Figures by Type
• 8.3 Asia Pacific IBS-C Drug Market Facts & Figures by Application

9 Latin America

• 9.1 Latin America IBS-C Drug by Country
  • 9.1.1 Latin America IBS-C Drug Sales by Country
  • 9.1.2 Latin America IBS-C Drug Revenue by Country
  • 9.1.3 Mexico
  • 9.1.4 Brazil
  • 9.1.5 Argentina
• 9.2 Central & South America IBS-C Drug Market Facts & Figures by Type
• 9.3 Central & South America IBS-C Drug Market Facts & Figures by Application

10 Middle East and Africa

• 10.1 Middle East and Africa IBS-C Drug by Country
  • 10.1.1 Middle East and Africa IBS-C Drug Sales by Country
  • 10.1.2 Middle East and Africa IBS-C Drug Revenue by Country
  • 10.1.3 Turkey
  • 10.1.4 Saudi Arabia
  • 10.1.5 U.A.E
• 10.2 Middle East and Africa IBS-C Drug Market Facts & Figures by Type
• 10.3 Middle East and Africa IBS-C Drug Market Facts & Figures by Application

11 Company Profiles

• 11.1 Catalent Pharmaceuticals Solutions
  • 11.1.1 Catalent Pharmaceuticals Solutions Corporation Information
  • 11.1.2 Catalent Pharmaceuticals Solutions Description and Business Overview
  • 11.1.3 Catalent Pharmaceuticals Solutions Sales, Revenue and Gross Margin (2015-2020)
  • 11.1.4 Catalent Pharmaceuticals Solutions IBS-C Drug Products Offered
  • 11.1.5 Catalent Pharmaceuticals Solutions Related Developments
• 11.2 Nestle
  • 11.2.1 Nestle Corporation Information
  • 11.2.2 Nestle Description and Business Overview
  • 11.2.3 Nestle Sales, Revenue and Gross Margin (2015-2020)
  • 11.2.4 Nestle IBS-C Drug Products Offered
  • 11.2.5 Nestle Related Developments
• 11.3 Abbott Laboratories
  • 11.3.1 Abbott Laboratories Corporation Information
  • 11.3.2 Abbott Laboratories Description and Business Overview
  • 11.3.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
  • 11.3.4 Abbott Laboratories IBS-C Drug Products Offered
  • 11.3.5 Abbott Laboratories Related Developments
• 11.4 Synergy Pharmaceuticals
  • 11.4.1 Synergy Pharmaceuticals Corporation Information
  • 11.4.2 Synergy Pharmaceuticals Description and Business Overview
  • 11.4.3 Synergy Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
  • 11.4.4 Synergy Pharmaceuticals IBS-C Drug Products Offered
  • 11.4.5 Synergy Pharmaceuticals Related Developments
• 11.5 Sucampo Pharmaceuticals
  • 11.5.1 Sucampo Pharmaceuticals Corporation Information
  • 11.5.2 Sucampo Pharmaceuticals Description and Business Overview
  • 11.5.3 Sucampo Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
  • 11.5.4 Sucampo Pharmaceuticals IBS-C Drug Products Offered
  • 11.5.5 Sucampo Pharmaceuticals Related Developments
• 11.6 Novartis Pharma
  • 11.6.1 Novartis Pharma Corporation Information
  • 11.6.2 Novartis Pharma Description and Business Overview
  • 11.6.3 Novartis Pharma Sales, Revenue and Gross Margin (2015-2020)
  • 11.6.4 Novartis Pharma IBS-C Drug Products Offered
  • 11.6.5 Novartis Pharma Related Developments
• 11.7 Astellas Pharmaceuticals
  • 11.7.1 Astellas Pharmaceuticals Corporation Information
  • 11.7.2 Astellas Pharmaceuticals Description and Business Overview
  • 11.7.3 Astellas Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
  • 11.7.4 Astellas Pharmaceuticals IBS-C Drug Products Offered
  • 11.7.5 Astellas Pharmaceuticals Related Developments
• 11.8 Ardelyx
  • 11.8.1 Ardelyx Corporation Information
  • 11.8.2 Ardelyx Description and Business Overview
  • 11.8.3 Ardelyx Sales, Revenue and Gross Margin (2015-2020)
  • 11.8.4 Ardelyx IBS-C Drug Products Offered
  • 11.8.5 Ardelyx Related Developments
• 11.9 Synthetic Biologics
  • 11.9.1 Synthetic Biologics Corporation Information
  • 11.9.2 Synthetic Biologics Description and Business Overview
  • 11.9.3 Synthetic Biologics Sales, Revenue and Gross Margin (2015-2020)
  • 11.9.4 Synthetic Biologics IBS-C Drug Products Offered
  • 11.9.5 Synthetic Biologics Related Developments
• 11.10 Teva Pharmaceutical Industries
  • 11.10.1 Teva Pharmaceutical Industries Corporation Information
  • 11.10.2 Teva Pharmaceutical Industries Description and Business Overview
  • 11.10.3 Teva Pharmaceutical Industries Sales, Revenue and Gross Margin (2015-2020)
  • 11.10.4 Teva Pharmaceutical Industries IBS-C Drug Products Offered
  • 11.10.5 Teva Pharmaceutical Industries Related Developments
• 11.1 Catalent Pharmaceuticals Solutions
  • 11.1.1 Catalent Pharmaceuticals Solutions Corporation Information
  • 11.1.2 Catalent Pharmaceuticals Solutions Description and Business Overview
  • 11.1.3 Catalent Pharmaceuticals Solutions Sales, Revenue and Gross Margin (2015-2020)
  • 11.1.4 Catalent Pharmaceuticals Solutions IBS-C Drug Products Offered
  • 11.1.5 Catalent Pharmaceuticals Solutions Related Developments
• 11.12 Ferring BV
  • 11.12.1 Ferring BV Corporation Information
  • 11.12.2 Ferring BV Description and Business Overview
  • 11.12.3 Ferring BV Sales, Revenue and Gross Margin (2015-2020)
  • 11.12.4 Ferring BV Products Offered
  • 11.12.5 Ferring BV Related Developments
• 11.13 Ironwood Pharmaceuticals
  • 11.13.1 Ironwood Pharmaceuticals Corporation Information
  • 11.13.2 Ironwood Pharmaceuticals Description and Business Overview
  • 11.13.3 Ironwood Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
  • 11.13.4 Ironwood Pharmaceuticals Products Offered
  • 11.13.5 Ironwood Pharmaceuticals Related Developments
• 11.14 Salix Pharmaceuticals
  • 11.14.1 Salix Pharmaceuticals Corporation Information
  • 11.14.2 Salix Pharmaceuticals Description and Business Overview
  • 11.14.3 Salix Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
  • 11.14.4 Salix Pharmaceuticals Products Offered
  • 11.14.5 Salix Pharmaceuticals Related Developments
• 11.15 Norgine
  • 11.15.1 Norgine Corporation Information
  • 11.15.2 Norgine Description and Business Overview
  • 11.15.3 Norgine Sales, Revenue and Gross Margin (2015-2020)
  • 11.15.4 Norgine Products Offered
  • 11.15.5 Norgine Related Developments
• 11.16 Prometheus Laboratories
  • 11.16.1 Prometheus Laboratories Corporation Information
  • 11.16.2 Prometheus Laboratories Description and Business Overview
  • 11.16.3 Prometheus Laboratories Sales, Revenue and Gross Margin (2015-2020)
  • 11.16.4 Prometheus Laboratories Products Offered
  • 11.16.5 Prometheus Laboratories Related Developments
• 11.17 Actavis Nordic
  • 11.17.1 Actavis Nordic Corporation Information
  • 11.17.2 Actavis Nordic Description and Business Overview
  • 11.17.3 Actavis Nordic Sales, Revenue and Gross Margin (2015-2020)
  • 11.17.4 Actavis Nordic Products Offered
  • 11.17.5 Actavis Nordic Related Developments
• 11.18 Albireo Pharma
  • 11.18.1 Albireo Pharma Corporation Information
  • 11.18.2 Albireo Pharma Description and Business Overview
  • 11.18.3 Albireo Pharma Sales, Revenue and Gross Margin (2015-2020)
  • 11.18.4 Albireo Pharma Products Offered
  • 11.18.5 Albireo Pharma Related Developments
• 11.19 Yuhan Corp
  • 11.19.1 Yuhan Corp Corporation Information
  • 11.19.2 Yuhan Corp Description and Business Overview
  • 11.19.3 Yuhan Corp Sales, Revenue and Gross Margin (2015-2020)
  • 11.19.4 Yuhan Corp Products Offered
  • 11.19.5 Yuhan Corp Related Developments
• 11.20 Astrazeneca
  • 11.20.1 Astrazeneca Corporation Information
  • 11.20.2 Astrazeneca Description and Business Overview
  • 11.20.3 Astrazeneca Sales, Revenue and Gross Margin (2015-2020)
  • 11.20.4 Astrazeneca Products Offered
  • 11.20.5 Astrazeneca Related Developments
• 11.21 The Menarini Group
  • 11.21.1 The Menarini Group Corporation Information
  • 11.21.2 The Menarini Group Description and Business Overview
  • 11.21.3 The Menarini Group Sales, Revenue and Gross Margin (2015-2020)
  • 11.21.4 The Menarini Group Products Offered
  • 11.21.5 The Menarini Group Related Developments
• 11.22 Ono Pharmaceutical
  • 11.22.1 Ono Pharmaceutical Corporation Information
  • 11.22.2 Ono Pharmaceutical Description and Business Overview
  • 11.22.3 Ono Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
  • 11.22.4 Ono Pharmaceutical Products Offered
  • 11.22.5 Ono Pharmaceutical Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

• 12.1 IBS-C Drug Market Estimates and Projections by Region
  • 12.1.1 Global IBS-C Drug Sales Forecast by Regions 2021-2026
  • 12.1.2 Global IBS-C Drug Revenue Forecast by Regions 2021-2026
• 12.2 North America IBS-C Drug Market Size Forecast (2021-2026)
  • 12.2.1 North America: IBS-C Drug Sales Forecast (2021-2026)
  • 12.2.2 North America: IBS-C Drug Revenue Forecast (2021-2026)
  • 12.2.3 North America: IBS-C Drug Market Size Forecast by Country (2021-2026)
• 12.3 Europe IBS-C Drug Market Size Forecast (2021-2026)
  • 12.3.1 Europe: IBS-C Drug Sales Forecast (2021-2026)
  • 12.3.2 Europe: IBS-C Drug Revenue Forecast (2021-2026)
  • 12.3.3 Europe: IBS-C Drug Market Size Forecast by Country (2021-2026)
• 12.4 Asia Pacific IBS-C Drug Market Size Forecast (2021-2026)
  • 12.4.1 Asia Pacific: IBS-C Drug Sales Forecast (2021-2026)
  • 12.4.2 Asia Pacific: IBS-C Drug Revenue Forecast (2021-2026)
  • 12.4.3 Asia Pacific: IBS-C Drug Market Size Forecast by Region (2021-2026)
• 12.5 Latin America IBS-C Drug Market Size Forecast (2021-2026)
  • 12.5.1 Latin America: IBS-C Drug Sales Forecast (2021-2026)
  • 12.5.2 Latin America: IBS-C Drug Revenue Forecast (2021-2026)
  • 12.5.3 Latin America: IBS-C Drug Market Size Forecast by Country (2021-2026)
• 12.6 Middle East and Africa IBS-C Drug Market Size Forecast (2021-2026)
  • 12.6.1 Middle East and Africa: IBS-C Drug Sales Forecast (2021-2026)
  • 12.6.2 Middle East and Africa: IBS-C Drug Revenue Forecast (2021-2026)
  • 12.6.3 Middle East and Africa: IBS-C Drug Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Porter's Five Forces Analysis
• 13.5 Primary Interviews with Key IBS-C Drug Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 IBS-C Drug Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details